DAFTAR
Added to

Sorry, there was a problem.

There was an error retrieving your Wish Lists. Please try again.

Sorry, there was a problem.

List unavailable.

A pre-specified analysis of the DAPA-CKD trial

dapa toto Dapagliflozin significantly reduced risk of kidney failure and prolonged survival in patients with CKD with or without type 2 diabetes.. Dapagliflozin reduced the risk of kidney failure and prolonged survival in participants with chronic kidney disease with and without type 2 diabetes, including

Keunggulan dapa toto

  • ✅ dapa toto Setiap Hari
  • ✅ Tanpa Deposit Awal
  • ✅ Bisa Dicoba Gratis